In women with diabetes, increasing hemoglobin A1c (HbA1c) levels in early pregnancy are associated with increasing risk of adverse pregnancy outcomes, according to a new report.
Read More »Byetta Approved for Use with TZD’s in Type 2 Diabetes
Amylin and Eli Lilly announced last Friday that the FDA has approved BYETTA(R) (exenatide) injection as an add-on therapy to improve blood sugar control in people with type 2 diabetes who have not achieved adequate control on a thiazolidinedione (TZD).
Read More »Spine Shrinks Early in Diabetic Nerve Condition
The size of the spinal cord is significantly diminished long before symptoms of nerve damage appear in adults with diabetes, British doctors report.
Read More »New Gene May Contribute to Development of Type 2 Diabetes
Scientists from the new interdisciplinary LIMES (Life & Medical Sciences) Centre at the University of Bonn have identified a new gene which could play an important role in the development of diabetes.
Read More »Drug Treatment Slows Macular Vision Loss in Diabetics
A drug commonly used to slow the loss of central vision has shown promise in stemming a common precursor of blindness in diabetics, which involves the same central light-sensitive area of retina, scientists report.
Read More »Diabetes Control Maintained with Physical Activity
New study suggests that just twice a week resistance training is helpful for maintaining control of blood sugar levels in adults with type 2 diabetes.
Read More »Weight Loss Nasal Spray Begins Clinical Trials
PYY nasal spray trial demonstrates it produces satiety and a 30% reduction in calorie intake.
Read More »Diabetes Not Linked to Alzheimer’s in Seniors
For older people with diabetes, the condition does not increase the likelihood that they’ll develop Alzheimer’s disease, according to a report in the medical journal Neurology.
Read More »Obesity Has a Microbial Component With Therapeutic Implications
Increasing ‘lean microbiota can help in reducing obesity.
Read More »Ezetimibe/Simvastatin Lowers LDL-C More Than Atorvastatin in Diabetics
Patients treated with ezetimibe/simvastatin, 10/20 mg/d achieved significantly greater mean reductions in LDL-C levels (-53.6%) than those treated with atorvastatin, 10 mg/d (-38.3%; or 20 mg/d (-44.6%).
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.